Moral hazard and prescription medicine use in Australia--the patient perspective
Author
Abstract
Suggested Citation
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Productivity Commission, 2001. "International pharmaceutical price differences," Others 0107004, University Library of Munich, Germany.
- Pawluch, Dorothy & Cain, Roy & Gillett, James, 2000. "Lay constructions of HIV and complementary therapy use," Social Science & Medicine, Elsevier, vol. 51(2), pages 251-264, July.
- Leibowitz, Arleen & Manning, Willard G. & Newhouse, Joseph P., 1985. "The demand for prescription drugs as a function of cost-sharing," Social Science & Medicine, Elsevier, vol. 21(10), pages 1063-1069, January.
- Donovan, Jenny L. & Blake, David R., 1992. "Patient non-compliance: Deviance or reasoned decision-making?," Social Science & Medicine, Elsevier, vol. 34(5), pages 507-513, March.
- Williams, Simon J. & Calnan, Michael, 1996. "The 'limits' of medicalization?: Modern medicine and the lay populace in 'late' modernity," Social Science & Medicine, Elsevier, vol. 42(12), pages 1609-1620, June.
- Conrad, Peter, 1985. "The meaning of medications: Another look at compliance," Social Science & Medicine, Elsevier, vol. 20(1), pages 29-37, January.
- Lupton, Deborah, 1997. "Consumerism, reflexivity and the medical encounter," Social Science & Medicine, Elsevier, vol. 45(3), pages 373-381, August.
- Murray, Joanna & Shepherd, Simon, 1993. "Alternative or additional medicine? An exploratory study in general practice," Social Science & Medicine, Elsevier, vol. 37(8), pages 983-988, October.
- Vuckovic, Nancy & Nichter, Mark, 1997. "Changing patterns of pharmaceutical practice in the United States," Social Science & Medicine, Elsevier, vol. 44(9), pages 1285-1302, May.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Loukas Balafoutas & Rudolf Kerschbamer & Matthias Sutter, 2017.
"Second‐Degree Moral Hazard In A Real‐World Credence Goods Market,"
Economic Journal, Royal Economic Society, vol. 127(599), pages 1-18, February.
- Loukas Balafoutas & Rudolf Kerschbamer & Matthias Sutter, 2013. "Second-Degree Moral Hazard in a Real-World Credence Goods Market," Economics Working Papers ECO2013/08, European University Institute.
- Balafoutas, Loukas & Kerschbamer, Rudolf & Sutter, Matthias, 2013. "Second-Degree Moral Hazard in a Real-World Credence Goods Market," IZA Discussion Papers 7714, Institute of Labor Economics (IZA).
- Loukas Balafoutas & Rudolf Kerschbamer & Matthias Sutter, 2013. "Second-Degree Moral Hazard in a Real-World Credence Goods Market," Working Papers 2013-26, Faculty of Economics and Statistics, Universität Innsbruck.
- Loukas Balafoutas & Rudolf Kerschbamer & Matthias Sutter, 2013. "Second-Degree Moral Hazard in a Real-World Credence Goods Market," CESifo Working Paper Series 4458, CESifo.
- Pedersen, Line Bjørnskov & Hess, Stephane & Kjær, Trine, 2016. "Asymmetric information and user orientation in general practice: Exploring the agency relationship in a best–worst scaling study," Journal of Health Economics, Elsevier, vol. 50(C), pages 115-130.
- O’Brien, Gary L. & Sinnott, Sarah-Jo & O’ Flynn, Bridget & Walshe, Valerie & Mulcahy, Mark & Byrne, Stephen, 2020. "Out of pocket or out of control: A qualitative analysis of healthcare professional stakeholder involvement in pharmaceutical policy change in Ireland," Health Policy, Elsevier, vol. 124(4), pages 411-418.
- Goldsmith, Laurie J. & Kolhatkar, Ashra & Popowich, Dominic & Holbrook, Anne M. & Morgan, Steven G. & Law, Michael R., 2017. "Understanding the patient experience of cost-related non-adherence to prescription medications through typology development and application," Social Science & Medicine, Elsevier, vol. 194(C), pages 51-59.
- Noerreslet, Mikkel & Jemec, Gregor B.E. & Traulsen, Janine M., 2009. "Involuntary autonomy: Patients' perceptions of physicians, conventional medicines and risks in the management of atopic dermatitis," Social Science & Medicine, Elsevier, vol. 69(9), pages 1409-1415, November.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Timmermans, Stefan & Tietbohl, Caroline, 2018. "Fifty years of sociological leadership at Social Science and Medicine," Social Science & Medicine, Elsevier, vol. 196(C), pages 209-215.
- Carla F. Rodrigues, 2020. "Self-medication with antibiotics in Maputo, Mozambique: practices, rationales and relationships," Palgrave Communications, Palgrave Macmillan, vol. 6(1), pages 1-12, December.
- Berry, Brandon & Apesoa-Varano, Ester Carolina, 2017. "Medication takeovers: Covert druggings and behavioral control in Alzheimer's," Social Science & Medicine, Elsevier, vol. 188(C), pages 51-59.
- Rodrigues, Carla F., 2021. "Communicative trust in therapeutic encounters: users’ experiences in public healthcare facilities and community pharmacies in Maputo, Mozambique," Social Science & Medicine, Elsevier, vol. 291(C).
- Zhou, Amy, 2016. "The uncertainty of treatment: Women's use of HIV treatment as prevention in Malawi," Social Science & Medicine, Elsevier, vol. 158(C), pages 52-60.
- Deml, Michael J. & Buhl, Andrea & Notter, Julia & Kliem, Paulina & Huber, Benedikt M. & Pfeiffer, Constanze & Burton-Jeangros, Claudine & Tarr, Philip E., 2020. "‘Problem patients and physicians’ failures': What it means for doctors to counsel vaccine hesitant patients in Switzerland," Social Science & Medicine, Elsevier, vol. 255(C).
- Pound, Pandora & Britten, Nicky & Morgan, Myfanwy & Yardley, Lucy & Pope, Catherine & Daker-White, Gavin & Campbell, Rona, 2005. "Resisting medicines: a synthesis of qualitative studies of medicine taking," Social Science & Medicine, Elsevier, vol. 61(1), pages 133-155, July.
- Stevenson, Fiona & Knudsen, Pia, 2008. "Discourses of agency and the search for the authentic self: The case of mood-modifying medicines," Social Science & Medicine, Elsevier, vol. 66(1), pages 170-181, January.
- Epstein, Steven, 2016. "The politics of health mobilization in the United States: The promise and pitfalls of “disease constituencies”," Social Science & Medicine, Elsevier, vol. 165(C), pages 246-254.
- Chiu, Stephen W.K. & Ko, Lisanne S.F. & Lee, Rance P.L., 2005. "Decolonization and the movement for institutionalization of Chinese medicine in Hong Kong: a political process perspective," Social Science & Medicine, Elsevier, vol. 61(5), pages 1045-1058, September.
- Andreassen, Hege K., 2011. "What does an e-mail address add? - Doing health and technology at home," Social Science & Medicine, Elsevier, vol. 72(4), pages 521-528, February.
- Céline Mercier, 1994. "Improving the quality of life of people with severe mental disorders," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 33(1), pages 165-192, August.
- Gianluca Baio & Laura Magazzini & Antonio Nicita & Fabio Pammolli & Massimo Riccaboni, 2003. "Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica - Impatto sull'Industria e Distorsioni nel Funzionamento del Mercato," Working Papers CERM 0-2003, Competitività, Regole, Mercati (CERM).
- Poltorak, Mike & Leach, Melissa & Fairhead, James & Cassell, Jackie, 2005. "'MMR talk' and vaccination choices: An ethnographic study in Brighton," Social Science & Medicine, Elsevier, vol. 61(3), pages 709-719, August.
- Lundberg, Lena & Johannesson, Magnus & Isacson, Dag G. L. & Borgquist, Lars, 1998. "Effects of user charges on the use of prescription medicines in different socio-economic groups," Health Policy, Elsevier, vol. 44(2), pages 123-134, May.
- Salas-Vega, Sebastian & Shearer, Emily & Mossialos, Elias, 2020. "Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the US," Social Science & Medicine, Elsevier, vol. 258(C).
- Viet-Thi Tran & Mariam Mama Djima & Eugene Messou & Jocelyne Moisan & Jean-Pierre Grégoire & Didier K Ekouevi, 2018. "Avoidable workload of care for patients living with HIV infection in Abidjan, Côte d’Ivoire: A cross-sectional study," PLOS ONE, Public Library of Science, vol. 13(8), pages 1-15, August.
- Morgan, Steve & McMahon, Meghan & Greyson, Devon, 2008. "Balancing health and industrial policy objectives in the pharmaceutical sector: Lessons from Australia," Health Policy, Elsevier, vol. 87(2), pages 133-145, August.
- Setti Rais Ali & Paul Dourgnon & Lise Rochaix, 2018.
"Social Capital or Education: What Matters Most to Cut Time to Diagnosis?,"
Working Papers
halshs-01703170, HAL.
- Setti Rais Ali & Paul Dourgnon & Lise Rochaix, 2018. "Social Capital or Education: What Matters Most to Cut Time to Diagnosis?," PSE Working Papers halshs-01703170, HAL.
- Ming Liu & Sumner la Croix, 2013.
"A Cross-Country Index of Intellectual Property Rights in Pharmaceutical Innovations,"
Working Papers
201313, University of Hawaii at Manoa, Department of Economics.
- Ming Liu & Sumner La Croix, 2014. "A Cross-Country Index of Intellectual Property Rights in Pharmaceutical Innovations," Working Papers 2014-13, University of Hawaii Economic Research Organization, University of Hawaii at Manoa.
- Ming Liu & Sumner La Croix, 2014. "A Cross-Country Index of Intellectual Property Rights in Pharmaceutical Innovations," Working Papers 201408, University of Hawaii at Manoa, Department of Economics.
More about this item
Keywords
Pharmaceuticals Moral hazard Prescription costs Patient demand Australia;Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:60:y:2005:i:7:p:1437-1443. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.